Since its first crystallization,
the aqueous structure of the tellurium-containing experimental drug
AS-101 has never been studied. We show that, under the aqueous conditions
in which it is administered, AS-101 is subjected to an immediate ligand-substitution
reaction with water, yielding a stable hydrolyzed oxide anion product
that is identified, for the first time, to be TeOCl3
–. Studying the structure of AS-101 in propylene glycol
(PG), an alcoholic solvent often used for the topical and oral administration
of AS-101, revealed the same phenomenon of ligand-substitution reaction
between the alcoholic ligands. Upon exposure to water, the PG-substituted
product is also hydrolyzed to the same tellurium(IV) oxide form, TeOCl3
–.